Details of the Drug
General Information of Drug (ID: DMOQE91)
Drug Name |
RU78191
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
Phenylmalonic acid; 2613-89-0; 2-Phenylmalonic acid; 2-phenylpropanedioic acid; Propanedioic acid, phenyl-; Phenylmalonicacid; Phenylpropanedioc acid; Malonic acid, phenyl-; RU78191; Propanedioic acid, 2-phenyl-; phenylpropanedioic acid; CHEMBL78794; .alpha.-Carboxyphenylacetic acid; WWYDYZMNFQIYPT-UHFFFAOYSA-N; Toluene-.alpha.,.alpha.-dicarboxylic acid; phenylmalonate; alpha-Carboxyphenylacetic acid; EINECS 220-044-6; Toluene-alpha,alpha-dicarboxylic acid; NSC 41697; NSC 27164; 2-Phenyl-malonic acid; 1o4p; AC1L2PIV
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 180.16 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 1.2 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 3 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 4 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||||||||